Related Experiment Videos
An insect antibacterial peptide-based drug delivery system.
Laszlo Otvos1, Mare Cudic, Brendon Y Chua
1The Wistar Institute, Philadelphia, Pennsylvania 19104, USA. Otvos@wistar.upenn.edu
Molecular Pharmaceutics
|June 29, 2005
Summary
Designed antibacterial peptides can deliver cargo into cells. A modified peptide successfully delivered an immune epitope into bacterial and mammalian cells, showing potential for new vaccines.
Area of Science:
- Biochemistry
- Immunology
- Cell Biology
Background:
- Proline-rich antibacterial peptides can penetrate cell membranes.
- This property suggests their potential for delivering therapeutic peptides.
- Understanding cell penetration mechanisms is key for drug delivery.
Purpose of the Study:
- To investigate the cellular uptake of native and engineered antibacterial peptides.
- To evaluate the potential of these peptides as carriers for peptidic cargo.
- To assess the immunogenicity and efficacy of peptide conjugates for vaccines.
Main Methods:
- Studied uptake of pyrrhocoricin and a dimeric analogue in bacteria (E. coli, S. aureus) and human cells (dendritic cells, fibroblasts).
- Constructed and tested a chimera of the engineered peptide and a MHC class I epitope.
- Assessed the immunogenicity and T-cell response in mice and activation of human dendritic cells.
Main Results:
- Native pyrrhocoricin showed differential uptake in bacteria and human cells.
- A designer analogue (Pip-pyrr-MeArg dimer) penetrated all tested cell types.
- A chimera of the dimer and an epitope successfully entered cells and elicited a strong cytotoxic T-cell response without toxicity.
Conclusions:
- Designed pyrrhocoricin analogues are effective carriers for delivering peptidic cargo across cell membranes.
- Peptide conjugates maintain the antigenic integrity of the cargo.
- These findings highlight the potential of engineered peptides for epitope-based vaccine development.